VINCA ALKALOIDS AND CELL PROLIFERATION
VINCA ALKALOIDS AND CELL PROLIFERATION
批准号:
3174626
负责人:
Awtar Ganju-Krishan
金额:
$9.47万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1987-11-30
中文摘要
长春碱(VLB)和长春新碱(VCR)是重要的抗肿瘤药物。
尽管这些生物碱与纺锤体蛋白(微管蛋白)结合,
导致有丝分裂停滞,已被认为是他们的基础,
尽管它们具有抗有丝分裂作用,但其细胞毒性作用的机制尚不清楚。
我们已经证明,在低VLB培养的药物敏感性淋巴母细胞中,
浓度时,发生广泛的细胞溶解,表明细胞表面
相关药物作用。 细胞表面微管蛋白的存在
可能是他们对药物敏感的原因 同样地,在细胞中,
在体外VLB,新的糖蛋白出现在细胞表面。 直接
这些细胞表面蛋白与药物转运机制的关系
并且肿瘤细胞群体中的抗性尚未阐明。 也不是
关于这些标志物与
VLB/VCR的细胞周期时相相关细胞毒性。 我们现建议
提取、纯化和浓缩微管蛋白和表面标记蛋白(100
和160 K M. W)。 单克隆
这些标记的抗体将被标记并用于关联
在标记物,药物转运和来自一个细胞的单个细胞的耐药性之间,
人口 我们将分析的外观和内容之间的关系
单个细胞上的标志物和细胞周期相关的
VLB/VCR的细胞毒性。 离心淘洗,密度梯度
分离和荧光激活细胞分选将用于
定量结合抗体的量,并收集选择性富集的
人口数量。 放射性标记药物将用于研究药物转运。
多参数流动分析将用于关联细胞周期阶段和
细胞表面标记。 与对细胞增殖影响的相关性
将在软琼脂试验和裸鼠异种移植中进行研究。
英文摘要
Vinblastine (VLB) and VIncristine (VCR) are important antitumor agents.
Although binding of these alkaloids to spindle proteins (tubulin),
resulting in mitotic arrest, has been suggested as the basis for their
antimitotic action, the mechanism for their cytotoxic action is not known.
We have shown that in drug sensitive lymphoblasts incubated with low VLB
concentrations, extensive cytolysis occurs suggesting a cell surface
related drug effect. The presence of cel surface tubulin in these cells
may account for their drug sensitivity. Similarly, in cells made resistant
in vitro to VLB, new glycoproteins appear on the cell surface. The direct
relation of these cell surface proteins to the mechanism of drug transport
and resistance in a tumor cel population has not been elucidated. Nor is
any information available on the relation between these markers and the
cell cycle phase related cytotoxicity of VLB/VCR. We now propose to
extract, purify and concentrate tubulin and surface marker proteins (100
and 160 K M.W) from drug sensitive and resistant cells. Monoclonal
antibodies to these markers will be labeled and used for correlation
between markers, drug transport and resistance in individual cells from a
population. We will analyze relation between the appearance and content of
the markers on individual cells and the cell cycle phase related
cytotoxicity of VLB/VCR. Centrifugal elutriation, density gradient
separation and fluorescence activated cell sorting will be used to
quantitate amount of bound antibodies and to collect selectively enriched
populations. Radiolabelled drugs will be used to study drug transport.
Multiparameter flow analysis will be used to correlate cell cycle stage and
cell surface labelling. Correlation with effects on cell proliferation
will be studied in soft agar assays and nude mice xenografts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Flow Cytometry to Detect Human Tumor Cells in Body Fluid
-
批准号:6637389
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:Awtar Ganju-Krishan
-
依托单位:
Flow Cytometry to Detect Human Tumor Cells in Body Fluid
-
批准号:6530452
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2002
-
负责人:Awtar Ganju-Krishan
-
依托单位:
COULTER ELITE ESP CELL SORTER
-
批准号:2286919
-
项目类别:
-
资助金额:$19.5万
-
财政年份:1996
-
负责人:Awtar Ganju-Krishan
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:2109339
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1994
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MODULATION OF DOXORUBCIN EFFLUX IN HUMAN SOLID TUMORS
-
批准号:3201823
-
项目类别:
-
资助金额:$11.37万
-
财政年份:1992
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MODULATION OF DOXORUBICIN EFFLUX IN HUMAN SOLID TUMORS
-
批准号:3509630
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1992
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MODULATION OF DOXORUBICIN EFFLUX IN HUMAN SOLID TUMORS
-
批准号:2098223
-
项目类别:
-
资助金额:$16.66万
-
财政年份:1992
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MODULATION OF DOXORUBICIN EFFLUX IN HUMAN SOLID TUMORS
-
批准号:2098222
-
项目类别:
-
资助金额:$18.4万
-
财政年份:1992
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS
-
批准号:3187516
-
项目类别:
-
资助金额:$16.97万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MIAMI-NATIONAL COOPERATIVE DRUG DISCOVERY GROUP--AIDS
-
批准号:3546749
-
项目类别:
-
资助金额:$122.94万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MIAMI-NATIONAL COOPERATIVE DRUG DISCOVERY GROUP--AIDS
-
批准号:3546746
-
项目类别:
-
资助金额:$118.54万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MIAMI-NATIONAL COOPERATIVE DRUG DISCOVERY GROUP--AIDS
-
批准号:3546752
-
项目类别:
-
资助金额:$103.42万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
COULTER CORPORATION EPICS 753 DYE LASER SYSTEM
-
批准号:3519659
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS
-
批准号:3187513
-
项目类别:
-
资助金额:$17.58万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MIAMI-NATIONAL COOPERATIVE DRUG DISCOVERY GROUP--AIDS
-
批准号:3546750
-
项目类别:
-
资助金额:$107.54万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
COOPERATIVE DRUG DISCOVERY GROUP--AIDS
-
批准号:3546747
-
项目类别:
-
资助金额:$26.76万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS
-
批准号:3187515
-
项目类别:
-
资助金额:$17.1万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS
-
批准号:3187514
-
项目类别:
-
资助金额:$17.08万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS
-
批准号:3187517
-
项目类别:
-
资助金额:$17.65万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
MIAMI-NATIONAL COOPERATIVE DRUG DISCOVERY GROUP--AIDS
-
批准号:3546751
-
项目类别:
-
资助金额:$106.87万
-
财政年份:1987
-
负责人:Awtar Ganju-Krishan
-
依托单位:
海外基金